Brown, Lisle/Cummings, Inc. Adaptive Biotechnologies Corp Transaction History
Brown, Lisle/Cummings, Inc.
- $376 Billion
- Q2 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 200 shares of ADPT stock, worth $2,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$2,078
Previous $1.49 Million
56.8%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
245Shares Held
152MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$312 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$136 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$116 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$69 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.48B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...